June e-Newsletter | Summer Months, Summer Fun

Each year, more than 300 million people travel on long-distance flights (more than four hours long), with the total number of long-distance trips (about 657 million) happening from Memorial Day to Labor Day. The summer months are, in fact, the perfect time to travel for some summer fun. As you plan your itinerary and pack your…

May e-Newsletter | Celebrate & Share During National Women’s Health Week

Join the National Blood Clot Alliance (NBCA) during National Women’s Health Week (NWHW), May 13-19, 2018, as we work with the Alexandra L. Rowan Memorial Foundation to provide women with life-saving information about birth control and blood clots, and to help them determine, along with their doctor, their risk for blood clots and their best birth control…

Celebrate & Share During National Women’s Health Week

Birth Control and Blood Clots: Know Your Risk There are more than 60 million women of child-bearing age in the United States, and the majority of them report using some form of birth control. In fact, the birth control pill is their number one choice. While research shows that the birth control pill is safe and…

FDA Approves Andexxa®

NEW DRUG APPROVAL: The U.S. Food & Drug Administration (FDA) has granted Portola Pharmaceuticals approval to market Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo], the first and only antidote indicated to reverse the anticoagulation effects of factor Xa inhibitors, such as Xarelto® (rivaroxaban) and Eliquis® (apixaban), when patients are experiencing uncontrolled or life-threatening bleeding. This is…

New Thrombophilia Resource

NBCA recently updated information on its website about thrombophilia or genetic blood clotting disorders, thanks to funding provided by Grifols USA. This resource provides an overview of thrombophilia and its many forms, discusses the risks and potential complications, summarizes the current perspectives about testing and diagnosis, and provides an overview of potential treatment options and…

April e-Newsletter | Sharing our Success

We at NBCA are always inspired by your enthusiasm for the work that we do, but never more so than during some of our more pronounced educational efforts, such as during Blood Clot Awareness Month, which we recognized last month. As spring kicks off, we’re excited to share a small sample of some of our Blood…

MASAB Memo, April 2018

MASAB Memo #6, April 16, 2018 The HOKUSAI VTE Cancer Study by Michael Streiff, MD, Professor of Medicine and Pathology, Johns Hopkins School of Medicine, Baltimore Cancer increases the risk of blood clots by 4-7 fold on average.1,2 Consequently, cancer is identified as a contributing risk factor in up to 20% of patients who suffer…

New Patient Preference Survey

Several hundred NBCA Facebook Followers participated in an online survey conducted by researchers at the University of Minnesota to evaluate patient concerns and preferences associated with both old and newer anticoagulant medications or “blood thinners.” NBCA is proud to have assisted with this work, and grateful to the University of Minnesota School of Public Health for recognizing…

March e-Newsletter | Blood Clot Awareness Month

March is Blood Clot Awareness Month, or BCAM, and an opportunity to share life-saving information about dangerous blood clots on a broad scale. It also provides an opportunity for you to lend your voice to these efforts and make a difference, by helping to increase public awareness about blood clots. Join NBCA this March and Raise…

MASAB Memo, March 2018

MASAB Memo #5, March 7, 2018 New Study Results – Clot-Busting Treatment by Suresh Vedantham, MD, Professor of Radiology & Surgery, Mallinckrodt Institute of Radiology, Washington University, St. Louis Each year, about 300,000 Americans are diagnosed with deep vein thrombosis (DVT, a blood clot in a leg vein) for the first time.  Despite the use of standard…